3-tert-Butyl-4-hydroxyanisole (BHA) is an antioxidant that is widely used in many countries as a food additive because its toxicity is regarded as low. Acceptable daily intake (ADI) prescribed by the Joint FAO/WHO Food Standard Program for BHA is 0-0.5 mg/kg/d. Daily intake of BHA in Japan in fiscal year 1996 was 0.105 mg per person, 1) which corresponds to only about 0.4% of the ADI assuming a body weight of 50 kg. Estimated daily intake of BHA is very low in the Netherlands, 2) Italy, 3) and Brazil. 4) However, since BHA is known to accumulate in adipose tissues, 5) its effect on humans is a matter of great concern.
Dietary BHA was found to reduce the incidence of colon cancer induced by methylazoxymethanol acetate in female CF1 mice. 6) BHA significantly reduced the genotoxic effects, such as the frequency of 6-thioguanidine resistant mutations and micronuclei, induced by N-methyl-NЈ-nitro-N-nitrosoguanidine (MNNG) in Chinese hamster V79 cells. 7) Exercise-induced thymocyte apoptosis in rats was blocked by treatment with BHA. 8) BHA also inhibited tumor necrosis factor (TNF)-induced cytotoxicity in mouse fibrosarcoma cells, 9, 10) and apoptosis induced by oxidative stress in neurons, 11) human leukemia cells, 12) and human monocytes and macrophages. 13) In contrast to the beneficial effects of BHA in animals or cultured cells, adverse effects have also been reported. At the dose of 0.5 or 2% (w/w) in the diet, BHA induced papillomas and squamous cell carcinoma in the forestomach of rodents. 14, 15) At doses that induce detoxifying enzymes, 15-60 mM, it induced apoptosis in human colon carcinoma cells. 16) Cytotoxic effects have been observed in human dermal fibroblasts, keratinocytes, melanocytes, and melanoma tumor cells. 17) Its cytotoxicity in rat hepatocytes was attributed to the induction of apoptosis through a molecular mechanism of direct release of cytochrome c and subsequent activation of caspases. 18) These beneficial and adverse effects of BHA might depend on its concentration and also on the nature of cells or tissues.
Fusi et al. 19) reported that BHA has a number of effects, that is, it increases proton leak through the mitochondrial inner membrane and inhibits the Dp (proton motive force across the mitochondrial inner membrane) generating system, but it has no effect on the phosphorylation system. BHA is cytotoxic to isolated rat hepatocytes and inhibits state 3 and slightly stimulates state 4 of mitochondrial respiration. 20) It also dissipates mitochondrial transmembrane potential and causes the release of calcium ions, mitochondrial swelling, and decrease in ATP levels in intact hepatocytes. 20) Though the cytotoxicity of BHA and its effects on mitochondria have been extensively studied, the biochemical mechanism of cell death caused by BHA is not yet fully understood. Further study such as analysis of the site where BHA influences cellular function is required to elucidate the precise mechanism of action.
In the present study, we investigated the pathways of cell death induced by BHA by examining caspase activity and cellular morphology and by the estimation of individual mitochondrial enzyme activities involved in oxidative phosphorylation, which plays the major role in the maintenance of mitochondrial structure and function, in human monocytic leukemia U937 cells which are frequently used in cytotoxicity studies.
A phenolic antioxidant 3-tert-butyl-4-hydroxyanisole (BHA) is a widely used food additive. BHA had cytotoxicity in human monocytic leukemia U937 cells. BHA at 0.75 mM caused nuclear condensation and fragmentation, structural damage in mitochondria, decrease in mitochondrial transmembrane potential, and internucleosomal DNA cleavage. It induced the activities of caspase-3 and/or -7, -6, -8 and -9, especially high when DEVD-MCA was the substrate (caspase-3 and/or -7). DEVDase activity increased in time-and dose-dependent manner and high activity was observed in lysates of cells treated for 3 h at 0.75 mM. Addition of GSH (reduced glutathione) during the treatment of cells with BHA inhibited the induction of DEVDase activity, and the intracellular GSH level decreased as the concentration of BHA was raised. Intracellular ATP levels decreased in time-and dose-dependent manner when the cells were treated with BHA in the presence or absence of glucose. Enzyme activities involved in the respiratory chain were assayed with the mitochondrial fraction prepared from U937 cells. BHA distinctly inhibited NADH-ubiquinone oxidoreductase (complex I) and cytochrome c oxidase (complex IV) at low concentrations. Succinate-ubiquinone oxidoreductase (complex II) was also inhibited, but to somewhat less extent. Without mitochondrial enzymes, BHA stimulated the ubiquinol-dependent reduction of cytochrome c (complex III), but it might have some detrimental effects on the mitochondrial enzyme reaction of complex III. The inhibition of mitochondrial oxidative phosphorylation might corroborate the mechanistic evidence for apoptosis of leukemia cells by BHA. Cell death induced by BHA is primarily ascribable to apoptosis. Cytotoxicity Cytotoxicity was determined by the measurement of LDH (lactate dehydrogenase) activity released from cells into the culture medium at 3 h after the addition of BHA with LDH Cytotoxicity Detection Kit (Takara Biochemicals) according to the manufacturer's protocol with 2ϫ10 4 cells in 200 ml of medium/well. One hundred microliters of medium was taken to determine LDH activity and the absorbance at 492 nm was measured with the reference at 620 nm. The percentage of LDH released in the growth medium, expressed as a function of total LDH release after the addition of Triton X-100 (final concentration 1% (v/v)), was used as the index of cytotoxicity.
Examination of the Morphology of Cells Cells were treated for 3 h with BHA at 0.75 mM, stained with 4Ј,6-diamidino-2-phenylindole dihydrochloride (DAPI), and then examined by fluorescence microscopy at the magnification of 400ϫ.
Cytoarchitectural characteristics were examined by means of electron microscopy. The growth medium was removed after treatment of cells with or without BHA for 3 h and replaced with PBS, pH 7.4, containing 2% (w/v) glutaraldehyde. Further fixation was carried out for 1 h with potassium ferricyanide in 1% (w/v) osmium tetroxide. Specimens were stained with 2% (w/v) aqueous uranyl acetate for 2 h and washed with water. Dehydration was performed with acetone, and cells were embedded in a mixture of epoxy resin and acetone. Samples were examined in a Hitachi H7100 TEM microscope at 75 kV. Photographs were taken at magnifications of 3200 and 24000.
Flow Cytometry Cells were stained with 5 mg/ml of JC-1, a sensitive and specific fluorescent probe for mitochondrial transmembrane potential (Dy), 23) at room temperature for 20 min, and mitochondrial permeability transition (Dy) was analyzed using a FACScalibur flow cytometer (Becton Dickinson, U.S.A.) equipped with a single 488 nm argon laser. The filter at the FL1 photomultiplier was 530 nm with a bandwidth of 30 nm, and that at FL2 was 585 nm with a bandwidth of 42 nm. The photomultiplier values of the detector in FL1 and FL2 were set at 376 V and 330 V, respectively. 6 cells/ml medium in 35-mm dishes were incubated in the presence or absence of BHA. To examine the effect of GSH (reduced glutathione), GSH was dissolved in distilled water and added to the culture medium before the addition of 0.75 mM BHA. After incubation with BHA, the cells were collected and washed with PBS without Ca ϩϩ or Mg ϩϩ . The lysis buffer (100 ml), consisting of Tris-HCl (pH 7.5) and 0.2% (v/v) Triton X-100, was added to the cells and the mixture was kept at 4°C for 30 min. The lysate was obtained as the supernatant after centrifugation at 12000ϫg for 10 min. The enzyme activity was assayed as described previously, 21) with substrate concentrations of 50 mM for Ac-DEVD-AMC and 100 mM for other substrates, and expressed as the amount of AMC cleaved per mg protein per min. Each activity was calculated by subtracting the control value obtained in the reaction with the lysates of cells treated with vehicle alone (DMSO) in the culture medium. Exceptionally, in dose-response and time-course experiments with BHA, DEVDase activity was expressed without correction. The protein concentration of the lysate was determined with a BioRad DC protein assay system. Statistical significance analysis was determined using the two-tailed Student's t-test (a p value of Ͻ0.01 was considered significant).
Western Blotting of Poly(ADP-ribose) Polymerase (PARP) Protein Cells were dissolved in a solution 24) containing 62.5 mM Tris-HCl, pH 6.8, 6 M urea, 10% (v/v) glycerol, 2% (w/v) SDS, 5% (v/v) b-mercaptoethanol, and 0.003% (w/v) bromophenol blue by sonication for 60 s with a Branson Sonifier B-12 (Danbury, Conn., U.S.A.) on ice. Twenty micrograms of protein was subjected to 7.5% SDS-PAGE and protein bands were transferred with a Semi-dry Transfer Cell (Transblot SD, Bio-Rad) to PVDF membrane (Hybond-P, Amersham Biosciences). After reaction with the primary antibody and peroxidase-conjugated second antibody in PBS containing 0.1% (v/v) Tween-20 and 5% (w/v) non-fat powdered milk (Block Ace Powder, Dainippon Pharmaceutical Co., Ltd.), the bands of peptides were visualized by chemiluminescent reagents (ECL plus, Amersham Biosciences) on Polaroid 667 film in Camlight 501 (Analytical Luminescence Laboratory, U.S.A.).
Determination of Reduced Glutathione Cytosolic reduced glutathione was determined by a fluorometric method 25) with slight modification. Briefly, U937 cells were collected in a tube after treatment with BHA and washed with PBS. GSH was extracted with cold 5% (v/v) perchloric acid. After the addition of o-phthalaldehyde, fluorescence with excitation at 350 nm and emission at 420 nm was measured with a Cytofluor II plate reader (Applied Biosystems). Protein was estimated by dissolving the acid precipitate in NaOH solution.
Preparation of Mitochondria U937 cells (2ϫ10 7 ) were collected, washed three times with 20 mM HEPES, pH 7.4, containing 300 mM mannitol, 1 mM EDTA and 0.1 mM PMSF and homogenized in the same buffer with 40 strokes in a glass-Dounce homogenizer (tight) on ice. The supernatant obtained by centrifugation at 600ϫg for 5 min was further centrifuged at 8000ϫg for 20 min to remove microsomes. The precipitate was washed by centrifugation at 8000ϫg for 20 min. The mitochondrial fraction was dissolved in the same buffer and stored at Ϫ80°C until use.
Assay of Respiratory Complexes Activities of individual enzymes of the mitochondrial respiratory chain were estimated essentially according to the methods of Cornelissen et al., 26) Trounce et al., 27) and Cardoso et al. 28) with modifications. BHA was added to the reaction mixture at the beginning of incubation. Each reaction was performed at 30°C. For the assay of complexes I, II, III, and IV, a Shimadzu Spectrophotometer Type UV-300 was used, and the activity was expressed as nmol/mg protein/min.
In the case of complex I activity, mitochondrial fraction (20 mg of protein) was incubated in a mixture containing 50 mM Tris-HCl buffer, pH 7.4, 1 mM EDTA, 250 mM sucrose, 2 mM KCN, 10 mM decylubiquinone (DB) and 0.6 mM n-dodecyl-b-D-maltoside. After a 1-min preincubation, the reactions were started by the addition of 50 mM NADH. Rotenone (5 mg/ml) sensitive activity was regarded as complex I activity. Oxidation of NADH was monitored at 340 nm with the reference at 380 nm.
In the case of complex II activity, mitochondrial fraction (25 mg) was incubated in 50 mM potassium phosphate buffer, pH 7.4, supplemented with 20 mM succinate, 2 mM KCN, 2 mg/ml antimycin A, 4 mg/ml rotenone, 0.6 mM n-dodecyl-b-D-maltoside, and 50 mM DCPIP. After a 2-min equilibration, the reaction was started by addition of 50 mM DB to the reaction mixture, and the decrease in absorbance at 600 nm with the reference at 750 nm was monitored. TTFA (0.5 mM) sensitive activity was regarded as complex II activity.
Complex III donates electrons from reduced decylubiquinone (ubiquinol) to cytochrome c, leading to the reduction of cytochrome c. Ubiquinol was prepared by reducing DB with sodium dithionite.
26) The complex III assay mixture contained 25 mM potassium phosphate buffer, pH 7.2, 1 mM EDTA, 2.5 mM MgCl 2 , 0.6 mM n-dodecyl-b-D-maltoside, 2 mM KCN, and 50 mM cytochrome c. After a 1-min preincubation, the reaction was started by the addition of 50 mM ubiquinol. The increase in absorbance was monitored at 550 nm with the reference at 540 nm. Antimycin A (5 mg/ml) sensitive activity was regarded as complex III activity. The effect of BHA on the apparent activity of complex III was determined in the absence of mitochondrial preparation with various concentrations of BHA in the reaction mixture.
Complex IV activity was estimated by measuring the oxidation of reduced cytochrome c. Reduced cytochrome c was prepared according to the method of Trounce et al. 27) The reaction mixture contained 25 mM potassium phosphate buffer, pH 7.4, 1 mM n-dodecyl-b-D-maltoside, and 20 mM reduced cytochrome c. After a 1-min preincubation, the reaction was started by addition of 48 mg of mitochondria. The decrease in absorbance was monitored at 550 nm with the reference at 540 nm. KCN (2 mM) sensitive activity was regarded as the complex IV activity.
Determination of Cellular ATP Level ATP was determined luminometrically with a Bioluminescence Assay Kit CLS II (Roche Diagnostics GmbH). In the case of glucosefree medium, collected cells were washed twice with glucose-free RPMI 1640 medium and incubated in a CO 2 incubator for 30 min before plating cells. Cells treated with BHA in glucose-containing RPMI 1640 medium (2 g/l) or glucosefree medium were dissolved in lysis buffer (100 mM Tris, 4 mM EDTA, pH 7.75) and boiled for 1 min. The supernatant obtained by centrifugation at 12000 rpm for 1 min was taken for the determination of ATP in a Luminometer LB96V (Wallac/Berthold).
RESULTS
Cytotoxicity of BHA Cytotoxicity of BHA estimated by the release of LDH in the culture medium increased dose-dependently from 3ϫ10 Ϫ5 M to 3ϫ10 Ϫ3 M, reaching higher than 80% with 3ϫ10 Ϫ3 M BHA after treatment of cells for 3 h (Fig. 1) .
Morphology of the Cells In BHA-treated cells, nuclei were condensed and fragmented, while control cells treated with vehicle alone were not stained with DAPI ( Fig. 2A) .
Nuclear condensation and fragmentation in cells after the treatment with 0.75 mM BHA for 3 h was also confirmed by electron microscopy (Fig. 2B-1 ). Higher magnification (Fig.  2B-2 ) demonstrated that mitochondrial structure was disrupted as compared with non-treated control cells. Degradation of cristae and mitochondrial membrane, and discontinuous structure of mitochondrial membrane were frequently observed. Single-layered mitochondrial membrane with almost total loss of intramitochondrial structure or vacuole-like structure was also detected. (Fig. 3) . The decrease in JC-1 aggregates indicated the disruption of mitochondrial transmembrane potential. The increase in signals in the upper and lower right quadrants from about 8% (7ϩϽ1) to 28% (3ϩ25) after the treatment of cells with BHA indicated a small shift of signals to higher FL1, which implied an increase in JC-1 monomers. When the cells were treated with BHA for a longer period (3 h), the fluorescence intensity of FL2 was lowered too drastically to detect signals in the plot area (data not shown).
DNA Ladder Formation on Agarose Gel Electrophoresis Characteristic internucleosomal DNA fragmentation was detected with 0.75 mM BHA at two time-points, 1.5 and 3 h (Fig. 4) . Fragmented bands seemed to increase with time, while they were not found in control.
Enzyme Activities of Caspases DEVDase (caspase-3 and/or -7) activity increased as the concentration of BHA was raised, when cells were treated for 3 h (Fig. 5A ). In the time-course experiments with 0.75 mM BHA, the activity increased with the length of treatment (Fig. 5B) . The recovery of protein up to 0.75 mM or 3 h was almost unchanged from that of control cells. However, it was extremely low with 1 mM BHA or at 4 h, probably because many cells died of cy- tolysis, and the apparent specific activity (activity/mg protein/min) was very high (shown with dotted lines in Fig. 5 ).
Since the activity of DEVDase was highly induced after treatment of cells with 0.75 mM BHA for 3 h, enzyme activities towards various caspase substrates were also examined (Table 1) . Caspase activities towards DMQD, VEID, IETD, and LEHD were induced, but only to a small extent compared to DEVDase. In contrast, YVADase was barely induced.
Cleavage of PARP in Cells Treated with BHA PARP is one of the targets of DEVDase since it contains the DEVD peptide sequence. The cleavage of PARP was observed in the cells treated with BHA. In addition to the original 116-kDa PARP protein, an 89-kDa peptide was detected (Fig. 6) . Considerable cleavage occurred as early as 0.5 h, and almost all the 116-kDa peptide was cleaved at 2.5 h. The cleavage might indicate the activation of DEVDase in BHA-treated cells.
Effect of GSH on DEVDase Induction by BHA GSH was included in the medium during treatment of cells with BHA for 3 h. When the concentration of GSH was higher than 10 mM in the growth medium, the induction of DEVDase activity was sharply decreased (Fig. 7A) . Almost complete inhibition was observed by about 25 mM GSH.
Intracellular GSH Level Intracellular thiol levels in the nonprotein fraction represent GSH. When the GSH level was estimated after treatment of cells for 3 h with various concentrations of BHA, it was barely affected by 0.5 mM BHA, but drastically decreased at 0.75 mM and 0.8 mM (Fig. 7B) .
Effect of BHA on Mitochondrial Enzymes Involved in Oxidative Phosphorylation
Among the individual enzyme complexes of the respiratory chain, the NADH-ubiquinone oxidoreductase (complex I) was severely inhibited by BHA (Fig. 8A) . Its activity was decreased to approximately 50% of control at 0.1 mM and to less than 10% at 0.75 mM. Cytochrome c oxidase (complex IV) was decreased to about 55% of control with 0.25 mM BHA. BHA also inhibited succinate-ubiquinone oxidoreductase (complex II), but its inhibition was not as great as that of complex I or IV. BHA inhibited the oxidative enzyme reactions of complexes I, II, and IV in a concentration-dependent manner with IC 50 values of approximately 0.1, 1.25, and 0.28 mM, respectively.
The mitochondrial fraction catalyzed the reaction of ubiquinol-cytochrome c reductase (complex III) depending on the amount of protein added in the mixture (Fig. 8B-1 ). In the absence of mitochondrial enzymes, however, BHA distinctly stimulated the reduction of cytochrome c in a concentration-dependent manner in the presence of ubiquinol ( Fig.  8B-2) . Ubiquinol in the reaction mixture was indispensable because cytochrome c reductase was not activated by 2.0 mM BHA in the absence of ubiquinol without the mitochondrial fraction. BHA itself is an antioxidant and might catalyze the ubiquinol-dependent reduction of cytochrome c. When BHA was included in the reaction mixture in the presence of mitochondria, the reduction of cytochrome c was slightly inhibited by low concentrations of BHA, 0.25 and 0.5 mM (Fig.  8B-3 ). However, a small increase (about 20%) in activity was observed with BHA at 2 mM, whereas the activity was decreased to about 76% by the addition of antimycin A. Though antimycin A abolished the mitochondrial enzyme activity without BHA as expected (Fig. 8B-1) , it only partly inhibited the activity in the presence of 2.0 mM BHA and mitochondria (Fig. 8B-3) , indicating that the remaining activity was the BHA-induced reduction of cytochrome c, but was not enzyme-dependent.
Effect of BHA on ATP Level Intracellular ATP level decreased as the concentration of BHA was raised when the cells were treated for 1 h. A drastic decrease to less than 10% of the initial level was observed with BHA at 0.75 mM and 0.5 mM in the presence and absence of glucose, respectively (Fig. 9A) . In the time-course experiment with 0.75 mM BHA, ATP decreased very rapidly, probably in less than 15 min (Fig. 9B) , while its level was barely changed without BHA in the presence or absence of glucose. The decrease was even sharper in the absence of glucose (Figs. 9A, B) .
DISCUSSION
The release of LDH in the medium is an indicator of the cytocidal response and represents the damage to cell integrity. Cytotoxicity of BHA observed in the range of concentration from 3ϫ10 Ϫ5 M to 3ϫ10 Ϫ3 M might correspond to the study by Thompson and Moldéus 20) which reported concentrations from 100 to 750 mM in isolated rat hepatocytes. Internucleosomal cleavage observed as DNA ladder (Fig. 4) is one of the typical features of apoptosis induced by BHA.
Fragmented nuclei stained with DAPI ( Fig. 2A) by the treatment of cells with BHA demonstrated the involvement of apoptotic processes in cytotoxicity of BHA. Electron microscopic analysis with higher magnification has shown that the mitochondrial structure was severely disrupted. Dissipation of Dym in mitochondria is an early event in apoptosis. 29) We demonstrated that BHA induced the disruption of mitochondrial transmembrane potential by flow cytometry with JC-1, which is a specific dye for mitochondria not like DiOC6(3) staining plasma membrane as well as mitochondria. 23) Single-layered vacuole-like structures caused by BHA may be explained by the swelling and disruption of the mitochondrial membrane, which might represent "secondary necrosis" 29) following apoptosis. Cysteine aspartases (caspases) are involved in cell death via apoptosis. 30, 31) Yu et al. 18) have shown that cytochrome c was released from mitochondria by treatment of rat hepatocytes with 0.5 mM BHA, and they concluded that cytotoxicity of BHA is due to the induction of apoptosis, which is mediated by the direct release of cytochrome c and subsequent activation of caspases. In the present study, DEVDase activity representing caspase-3 and/or -7 was distinctly induced, and it was confirmed by the cleavage of PARP (Fig. 6 ). These results indicated a commitment to caspase-3 and/or -7-induced cell death. The significant increase in DMQDase activity (caspase-3 activity specific) upon treatment of cells with BHA (Table 1) pase-8, -6 and granzyme B), and LEHD (caspase-9) activities suggested that BHA might contribute to the activation of all of the 'initiator' caspases (e.g., caspase-8, -9, and -10) and 'effector' caspases (e.g., caspase-3, -6 and -7) in apoptosis. 31) BHA has been reported to inhibit primarily the action of NAD ϩ -and FAD-linked dehydrogenase systems, leading to the cessation of oxidative phosphorylation and a rapid depletion of the ATP supply, which, in turn would lead to a decrease in the activity of energy-dependent processes. 32, 33) The question of which reaction of oxidative phosphorylation is affected by BHA has not been clearly answered. In the present study, by the assay of the individual enzyme complexes of oxidative phosphorylation, BHA was found to inhibit complexes I, II and IV (Fig. 8A) . The effect of BHA on complex III was unique: BHA is an antioxidant and it stimulated the reduction of cytochrome c in the presence of ubiquinol without an enzyme (Fig. 8B-2) . Since the inhibition of mitochondrial complex III activity by BHA at low concentration was observed (Fig. 8B-3) , BHA obviously had a detrimental effect on the activity of complex III. Ubiquinol, reduced ubiquinone, itself is an antioxidant and prevents apoptotic features such as caspase activation, cytochrome c release, and disruption of mitochondrial transmembrane potential. 34) Physiologically, ubiquinol and ubiquinone are recycled in mitochondria to promote oxidative phosphorylation. However, the conversion of ubiquinol to ubiquinone, whose reaction is coupled with the reduction of cytochorome c via several steps, might be inhibited in the presence of BHA, and all of the processes of oxidative phosphorylation might be deranged. It was suggested that BHA blocked the electron flow by acting on multiple sites.
Intracellular GSH level was decreased by treatment of the cells with BHA (Fig. 7B ) in the range of concentrations causing cytotoxicity and DEVDase activity. The reduction in glutathione level is a part of the sequence of events leading to apoptosis and occurs when the mitochondrial transmembrane potential is completely disrupted. 29) A condition causing GSH depletion culminates in a loss of mitochondrial function, particularly the decreases in activities of complexes I, II, and IV of the respiratory chain. 35) We observed that BHA had a potential to inhibit complexes I, II and IV (Fig.  8A) as mentioned above.
It has been shown that exogenous GSH is rapidly transported across the plasma membrane of renal cells. 36, 37) The addition of GSH to U937 cells actually inhibited DEVDase activity (Fig. 7A) , but the effective concentration was relatively high. The efficiency of exogenous GSH to exert its effect inside the cells may depend on cellular differences in transport ability. However, on the basis of the study on the effects of exogenous GSH, it is likely that GSH, at least partly, is involved in defense against apoptotic cell death by BHA.
ATP is required for the execution of apoptosis and the conditions of ATP depletion lead to necrosis. 38) In particular, when the ATP level drops below 15-25% of the control level, cells die of necrosis.
39) The ATP level was drastically lowered within 60 min by treatment of cells with BHA (Fig.  9) . These results might correspond to those of Thompson and Moldéus 20) who observed a rapid drop in ATP levels with 750 mM BHA in rat hepatocytes. Drastic decrease in ATP with BHA at a concentration higher than 0.75 mM or at a later stage of treatment with 0.75 mM BHA (Fig. 9 ) may suggest that a large number of cells die of cytolysis. Cytolysis occurs secondary to apoptosis when dying cells fail to be removed by heterophagy. 29) A rapid and sharp drop in ATP might be ascribable to blocking of the steps in mitochondrial oxidative phosphorylation. Since the depletion of glucose accelerated the decrease in ATP, it is speculated that ATP generation in glycolysis (TCA cycle) was also inhibited by BHA.
In conclusion, BHA causes typical apoptosis of human monocytic leukemia U937 cells, with characteristic morphological changes that include nuclear fragmentation, internucleosomal DNA cleavage, caspase activation and decrease in mitochondrial transmembrane potential. GSH and ATP levels were decreased. The present study revealed that BHA inhibited the mitochondrial respiratory chain at multiple sites, complexes I, II, and IV, by the assay of individual enzyme complexes. It inhibited complex III as well, though BHA itself works as an electron-transferring compound and apparently stimulated the reduction of cytochrome c non-enzymatically in the presence of ubiquinol. BHA was found to inhibit mitochondrial oxidative phosphorylation and cause cell death, primarily through the series of events in the apoptotic cascade.
Apoptosis by BHA was most effectively observed at the rather high concentration of 0.75 mM. However, since there is a report that it caused apoptosis at 15-60 mM in human colon carcinoma cells, 16) it is plausible that versatile results could be obtained depending on the experimental systems. Moreover, molecular and cellular events caused by BHA, even at low concentrations, might eventually lead to apoptosis. The data in the present study with U937 cells, a type of human cancerous cell, would be instrumental for obtaining a better understanding of apoptotic cell death caused by BHA.
